139 PROSTAGLANDIN F_2α COMPROMISES DEVELOPMENT OF PRE-IMPLANTATION BOVINE EMBRYOS DURING COMPACTION

Abstract

Several studies have implicated prostaglandin F_2α (PGF) as a major embryotoxic factor during early embryonic development in cattle. Elevated uterine concentrations of PGF were negatively associated with embryo development, quality and pregnancy rates (Schrick FN et al. 1993 Biol. Reprod. 49, 617–621; Hockett ME et al. 1998 J. Anim. Sci. 76 (Suppl 1), 241 abst; Seals RC et al. 1998 Prostaglandins 56, 377–389). Moreover, addition of PGF to culture medium decreased hatching rates of compacted morulae (Scenna FN et al. 2002 Theriogenology 53, 512 abst) and decreased development of pre-compacted (16–32 cell) bovine embryos to blastocyst stage (Scenna FN et al. 2003 Theriogenology 59, 335 abst). Furthermore, administration of an inhibitor of PGF synthesis at the time of embryo transfer improved pregnancy rates in cattle (Schrick FN et al. 2001 Theriogenology 55, 370 abst). The objective of the current study was to identify the period of time during early embryonic development that is most susceptible to the deleterious effects of PGF. After in vitro maturation and fertilization of bovine oocytes, putative zygotes were cultured in KSOMaa plus 0.3% BSA. On Day 4 post-insemination, pre-compacted (16–32 cell) embryos were removed from culture, evaluated for quality, and randomly assigned to one of the following treatments: 1) Control (KSOMaa plus 0.3% polyvinyl alcohol (KSOM-PVA; n = 470) or 2) PGF-1 (1 ng mL⁻¹ PGF in KSOM-PVA; n = 473; Scenna FN et al. 2003 Theriogenology 59, 335 abst). After 48 h of incubation in assigned treatments, assessment of development to compacted morula stage was determined. Thereafter, embryos were kept separate according to treatments, sorted by stage of development and quality, and randomly assigned to receive either Control (CON) or PGF-1 supplemented medium until assessment of blastocyst development on Day 9. This random sorting resulted in the formation of four treatment groups comprising the initial treatments and assigned treatments during Days 6–9 (CON-CON, n = 366; PGF-CON, n = 226; CON-PGF, n = 149; PGF-PGF, n = 287). Analyses were performed incorporating a randomized incomplete block design using mixed models of SAS (2000) to determine effects of PGF on Days 4–6, 6–9 and 4–9 of development. Data were also analyzed using chi-square. Addition of 1 ng mL⁻¹ of PGF to culture medium on Days 4–9 decreased the percentage of pre-compacted embryos reaching blastocyst stage (CON-CON, 47.8%; PGF-PGF, 36%; P < 0.05). Moreover, addition of 1 ng mL⁻¹ of PGF to the culture medium of pre-compacted bovine embryos on Days 4–6 of development decreased the percentage of compacted morulae on Day 6 (Control, 68.1%; PGF-1, 60.5%; P = 0.01). However, the percentage of embryos developing to blastocyst was not decreased following addition of 1 ng mL⁻¹ of PGF on Days 6–9 of development (CON-CON, 47.8%; CON-PGF, 42.6%; P > 0.05). Results suggest that morula stage embryos during compaction are most susceptible to deleterious effects of PGF.